Friday, July 10, 2026

pharma · CXCR4 · Uterine Cervical Neoplasms

Zhongnan Hospital

Zhongnan Hospital clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
5
Patents
0
Intelligence · Clinical Programs

Zhongnan Hospital projects

2 ClinicalTrials.gov programs sponsored by Zhongnan Hospital.

Zhongnan Hospital has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 68Ga-pentixafor

    Zhongnan Hospital

    CXCR4

    small molecule active

    1 trial
  2. Hydrochloride anlotinib

    Zhongnan Hospital

    Uterine Cervical Neoplasms

    small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Zhongnan Hospital have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.